KLAC
케이엘에이
Source: dsi_quarterly · analyst_consensus (internal DB). DSI from quarterly filings; consensus as of collection.
Suppliers
—
KLA Corporation
Customers
Competitors
Notes
KLA is the dominant process control vendor with roughly 50%+ share of wafer inspection and overlay/CD metrology, a near-monopoly position that scales with EUV adoption and advanced-node complexity. Process control intensity rises at 3nm/2nm and in HBM/advanced packaging, supporting structurally high gross margins. Key risks: US export controls on China shipments (a meaningful revenue share) and cyclical WFE capex swings.
KLA filed its annual 10-K for the fiscal year ended June 30, 2026, covering full-year financials, business conditions, risk factors, and MD&A. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for revenue and margin trends amid ongoing WFE spending cycles, China exposure updates, and any changes to forward guidance or capital allocation.
KLA filed an 8-K under Item 8.01 (Other Material Events), a catch-all category covering disclosures that don't fit standard triggers such as earnings or agreements. Without fetching the filing body, the specific event is unknown — common 8.01 uses include press releases on business developments, capital allocation actions, or regulatory matters. Full filing body not analyzed; description inferred from form + item codes. PMs should pull the exhibit under Item 9.01 to identify the actual event before drawing conclusions.
KLA Corporation filed an 8-K under Item 2.02 disclosing quarterly operating results, likely covering fiscal Q4 2026 given the late-July filing date aligned with KLA's June fiscal year-end. PMs should watch for WFE demand signals, process-control equipment revenue trends, and forward guidance — all direct read-throughs to KR/TW chipmaker capex and leading-edge fab ramp timelines. Full filing body not analyzed; description inferred from form + item codes.
Item 5.03 indicates KLA amended its bylaws or articles of incorporation, with Item 9.01 attaching the updated governing document as an exhibit. Such amendments are typically governance housekeeping (advance-notice provisions, officer indemnification, forum-selection clauses) rather than control-altering changes, though shareholder-rights language warrants a quick read. Full filing body not analyzed; description inferred from form + item codes.
KLA filed an 8-K under Item 8.01 (Other Material Events) with supporting exhibits under Item 9.01. Item 8.01 is a catch-all used for press releases, capital actions, litigation updates, or strategic announcements that don't fit other items — for a WFE leader like KLA this could move sentiment around China export controls, buybacks, or major contract news. Full filing body not analyzed; description inferred from form + item codes.
KLA filed its 10-Q for the quarter ended 2026-03-31, covering process control and wafer inspection results that PMs use to gauge WFE spending and leading-edge fab capex by TSMC, Samsung, and SK hynix. Watch China revenue mix, services growth, and any guidance commentary tied to NA/HBM/advanced packaging demand. Full filing body not analyzed; description inferred from form + item codes.
8-K filed under Item 2.02 indicates KLA released quarterly earnings, with Item 9.01 covering the press release exhibit. PMs should focus on revenue, gross margin, and any commentary on WFE demand, China exposure, and HBM/leading-edge process tool orders. Full filing body not analyzed; description inferred from form + item codes.
Full filing body not analyzed; description inferred from form + item codes. 8-K Item 7.01 (Reg FD) likely contains updated commentary or forward guidance from KLA — material for PMs given KLA's bellwether status in WFE/process control and read-through to memory/foundry capex (Samsung, SK Hynix, TSMC). Item 8.01 suggests an additional material event disclosed alongside; watch for revisions to revenue/margin outlook or commentary on China export controls and leading-edge demand.
Item 8.01 signals a non-routine material event KLA chose to disclose outside other 8-K categories, with Item 9.01 attaching supporting exhibits. Without specifics, this could range from a corporate action or legal/regulatory update to a capital-markets or strategic announcement relevant to wafer-fab equipment demand. Full filing body not analyzed; description inferred from form + item codes — PMs should pull the exhibits to gauge whether it touches WFE outlook, China export controls, or buyback/dividend policy.
Quarterly filing from KLA covering the period ended 2025-12-31, expected to detail process control / metrology equipment revenue, gross margin, services growth, backlog, and segment commentary tied to leading-edge logic and HBM/DRAM capex. PMs should compare bookings momentum and China revenue mix versus ASML and AMAT prints, and watch service attach as a margin anchor. Full filing body not analyzed; description inferred from form + item codes.
Filing pairs Item 2.02 (earnings results) with Item 9.01 (supporting exhibits), indicating KLA released quarterly results with a press release attached. PMs should focus on process control WFE demand, leading-edge logic/HBM-related orders, services growth, and any commentary on China exposure and shipment guidance. Full filing body not analyzed; description inferred from form + item codes.